Monday, July 17
|15:00||Arrival & Registration|
|17:00||Ice Breaker – Join us on the front lawn for falconry and archery|
Welcome & Participant Self-Introductions:
Fireside Chat: The Purposeful CEO—A seasoned advisor’s view on an industry in continual transformation and the CEOs that are leading the transformation
Networking Dinner Reception
|22:00||Conclusion of Opening Events|
Tuesday, July 18
Overview and Rules of Engagement
Introduction of CEO Self-Assessment & Flash Surveys
DISCUSSION 1: Setting the Strategic Direction—Are the Best Opportunities Aligned to Your “Reason for Being”?
DISCUSSION 2: Strategic Direction and The Board – When and how do you engage them in strategic discussions?
DISCUSSION 3: Planning for approval and commercialization early in the development process—Which steps are necessary and which are a waste of time and money?
|12:15||Networking Lunch at Sika|
DISCUSSION 4: Maximizing returns—How do you balance your shareholders’ needs, patient access, perception of your company, and perception in the industry?
DISCUSSION 5: Money—Which of the different flavors of capital for public and private companies is best for you? (Break out into two groups)
An unguarded conversation among CEOs and friends—Barriers to building a thriving European biotech community – are times changing?
|16:30||BIOTECH CEO SUMMIT GAMES|
|18:30||GALA DINNER AND AWARDS|
Wednesday, July 19
DISCUSSION 6: Communications strategy—What is the right story for your company and how do you set the stage to deal with adversity?
DISCUSSION 7: Dancing with bears —What makes for a successful alliance between “big” pharma and “small” biotech, and what makes them fail?
DISCUSSION 8: Team development—Does the company’s early team have the diversity of backgrounds and perspectives for later success?
DISCUSSION 9: Board development—How do you prod your board toward adapting to new realities and get them in alignment with your vision?
|12:30||Networking Lunch at Sika|
An unguarded conversation among CEOs and friends—The characteristics of a successful biotech CEO
DISCUSSION 10: Critical inflection points – How have you survived the make or break moments that led to success?